Cheryl Cohen insider trades

Open-market stock purchases and sales by Cheryl Cohen, Director at ImmunityBio, Inc, from SEC Form 4 filings since Sep 15, 2011.

Recent trades

DateStockTradeValue
Jul 2, 2026IBRX ImmunityBio, IncSold$1.2M
Jul 2, 2026IBRX ImmunityBio, IncBought (not open market)—
Jun 25, 2026CLDX Celldex Therapeutics, IncBought (not open market)—
Jun 9, 2026IBRX ImmunityBio, IncBought (not open market)—

Companies traded

  • IBRX ImmunityBio, Inc: 5 sales, last Jul 2, 2026
  • CLDX Celldex Therapeutics, Inc: other filings, last Jun 25, 2026
  • MEIP MEI Pharma, Inc: other filings, last Jul 5, 2022
  • ARPO Aerpio Pharmaceuticals, Inc: other filings, last Jun 30, 2021
  • NK NantKwest, Inc: 1 sale, last Aug 11, 2020
  • NVUS Novus Therapeutics, Inc: other filings, last Jul 11, 2019
  • VTL Vital Therapies Inc: 1 buy, 1 sale, last Sep 12, 2018
  • TKAI Tokai Pharmaceuticals Inc: other filings, last Jun 16, 2016
  • CYTR Cytrx Corp: other filings, last Dec 15, 2015
  • MDVN Medivation, Inc: 5 sales, last Feb 18, 2014

Get free alerts when Cheryl Cohen files a new trade →